These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28160473)

  • 1. Antimicrobials and QT prolongation.
    Mason JW
    J Antimicrob Chemother; 2017 May; 72(5):1272-1274. PubMed ID: 28160473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial-associated QT interval prolongation: pointes of interest.
    Owens RC; Nolin TD
    Clin Infect Dis; 2006 Dec; 43(12):1603-11. PubMed ID: 17109296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation.
    Niedrig D; Maechler S; Hoppe L; Corti N; Kovari H; Russmann S
    Eur J Clin Pharmacol; 2016 Jul; 72(7):859-67. PubMed ID: 27023463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proarrhythmic potential of antimicrobial agents.
    Simkó J; Csilek A; Karászi J; Lorincz I
    Infection; 2008 Jun; 36(3):194-206. PubMed ID: 18454341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [QTc-prolonging drugs and the risk of sudden death].
    Reingardiene D; Vilcinskaite J
    Medicina (Kaunas); 2007; 43(4):347-53. PubMed ID: 17485963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT prolongation with antimicrobial agents: understanding the significance.
    Owens RC
    Drugs; 2004; 64(10):1091-124. PubMed ID: 15139788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM
    J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval.
    Iannini PB
    Expert Opin Drug Saf; 2002 Jul; 1(2):121-8. PubMed ID: 12904146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin-induced proarrhythmia and cardiovascular death.
    Howard PA
    Ann Pharmacother; 2013 Nov; 47(11):1547-51. PubMed ID: 24285766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial agents-associated with QT interval prolongation.
    Bril F; Gonzalez CD; Di Girolamo G
    Curr Drug Saf; 2010 Jan; 5(1):85-92. PubMed ID: 20210724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
    Briasoulis A; Agarwal V; Pierce WJ
    Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action.
    Dhanani TC; Mantovani EH; Turner JR
    Int J Pharm Pract; 2017 Apr; 25(2):176-179. PubMed ID: 27677250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting drug-induced QT prolongation and torsades de pointes.
    Roden DM
    J Physiol; 2016 May; 594(9):2459-68. PubMed ID: 26660066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department approach to QTc prolongation.
    Pourmand A; Mazer-Amirshahi M; Chistov S; Sabha Y; Vukomanovic D; Almulhim M
    Am J Emerg Med; 2017 Dec; 35(12):1928-1933. PubMed ID: 28855066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-Mediated Effects on Potassium Channel Expression.
    Lazzerini PE; Acampa M; Laghi-Pasini F; Bertolozzi I; Finizola F; Vanni F; Natale M; Bisogno S; Cevenini G; Cartocci A; Giabbani B; Migliacci N; D'Errico A; Dokollari A; Maccherini M; Boutjdir M; Capecchi PL
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008627. PubMed ID: 32654514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lengthening of QT interval by antipsychotic drugs].
    Haverkamp W; Deuschle M
    Nervenarzt; 2006 Mar; 77(3):276, 278-80, 282-4 passim. PubMed ID: 16052325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.